Parallel Advisors LLC Buys 346 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Parallel Advisors LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 0.9% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 40,902 shares of the exchange traded fund’s stock after purchasing an additional 346 shares during the quarter. […]

Leave a Reply

Your email address will not be published.

Previous post Trudy Rubin: The roots and nuances of the Israel-Hamas war
Next post Parallel Advisors LLC Has $3.16 Million Stock Holdings in Starbucks Co. (NASDAQ:SBUX)